LIGAND PHARMACEUTICALS (LGND)

12.81 +0.15  +1.18%  May 30, 10:32AM Go Pro
You must be signed in to use watchlists.
Sign In or Register
Watch this stock

LIGAND PHARMACEUTICALS Capital Expenditures: 0.006M

Get Interactive Chart for


of


Select a metric
 
Date range: to
<Embed Chart> Pro Save as Image Pro Data Export
Copy the code below and paste
into the embed destination.
  Done
Attention OK

LGND Capital Expenditures Rankings

Overall 77th percentile 984 of 4457
Sector 72nd percentile 138 of 507 in Healthcare
Industry 78th percentile 3 of 14 in Drugs - Generic

LGND Capital Expenditures Range, Past 5 Years

Minimum 0.00 Dec 2010
Maximum 3.063M Jun 2010
Average 0.3011M

About Capex

Capital expenditures are a line item from a company's statement of cash flows (click "Learn More" below for details).

Capex (short for capital expenditures) are incurred when a business spends money to purchase fixed assets or to add value to an existing fixed asset. In accounting, a capital expenditures are added to an asset account, thus increasing the value of the asset.

Examples of capital expenditures include the purchase of a new manufacturing plant, investment in server farms for tech companies, or other purchases of assets expected to help the company earn profits in the future.

Unlike other investments like research and development and marketing spending, capital expenditures are not immediately expensed. Rather, property, plant and equipment acquired using capital expenditures are usually expensed over time through the use of depreciation.
Learn More

You may also be interested in these LGND related companies

Display in Live Stream: Done
Options

LGND News

$LGND may extend last week&#39;s move to 14.50, we got buy signal 5/24 which may last 14 days. Target price 14.50
about 3 days ago by woowtrading
$LGND Insider Sale: $2.3M of stock sold by David Knott on May 24, 2012 http://stks.co/3zbT
about 5 days ago by MarketBrief
$LGND Buying @10.50.
about 5 days ago by PaarnM
Health Care Sector Wrap
May 24, 5:45PM
$LGND Ligand partner abstracts posted for ASCO 2012 for Promacta, Kyprolis, CUDC-101 and ME-143 http://stks.co/3sZF
about 13 days ago by Ligand_LGND
$lgnd at the top of the list for tomorrow. panel next month and pdufa in June. chart looks like a bottom or at least close to it
about 13 days ago by russe9
$LGND amended latest Annual Report http://stks.co/3rYA
about 14 days ago by MarketBrief
$LGND presents at Merril Lynch Healthcare on Thursday, Jeffries on June 4, and has a panel date on 6/20.
about 15 days ago by britepathos
$LGND ---- http://stks.co/3kxA
about 21 days ago by MrDowJones
$LGND filed latest Quarterly Report http://stks.co/3fU0
about 26 days ago by MarketBrief
$LGND in AH @ 12.80
about 28 days ago by johnkelly
$lgnd S.holders like the share &lt;$12. So do I.
about 28 days ago by PaarnM
$LGND to report earnings results on May 2nd at 4:30 pm ET. Webcast/cc at: http://stks.co/3Z5U
about 32 days ago by abubnic
$LGND This week&#39;s top stories in technology 4/23-4/27 http://stks.co/3Z4k
about 32 days ago by ericjones12398
$LGND Ligand partner Merck posted May 2012 as start date for P3 Dinaciclib evaluation study on http://stks.co/3YYR http://stks.co/3YYS
about 33 days ago by Ligand_LGND
$LGND Ligand Captisol partner Onyx announced FDA Advisory Committee, ODAC, to review NDA for Carfilzomib on June 20 http://stks.co/3WrZ
about 34 days ago by Ligand_LGND
$LGND Ligand partner GSK reported Promacta sales of $43M in Q1, more than doubling compared to $19 million in Q1 2011, http://stks.co/3VQE
about 35 days ago by Ligand_LGND
$LGND Clinical study of Ligand’s LGD-4033 (SARM) program published in most recent Journal of Gerontology http://stks.co/3Edn
about 55 days ago by Ligand_LGND
Avoid This Biotech Stock
Mar 29, 10:20AM Fool
$spnc $fmx $ks $gel $lgnd on Equities Research @StockTwits
about 77 days ago by EquitiesResearch
@ChartSwingTrade I would say $HSFT,$LGND, $GMAN, $KIRK look great to me even before scanning for tomorrow
about 79 days ago by ivan_bg
$LGND over 16 looks like a decent swing trade to ~20. Beware It&#39;s lightly traded.
about 80 days ago by Contrarius
$LGND Simple math: $150 mm revs x 90% GM&#39;s = $135 Gross profit - $35 mm opex = $100 mm profit / 20 mm O/S = $5 EPS
about 85 days ago by PJAG2
$LGND Ligand partner Onyx completes ASPIRE P3 enrollment for Carfilzomib; completion of NDA review expected by July 27 http://stks.co/2Zk8
about 93 days ago by Ligand_LGND
Ligand Licenses DARA Program to Retrophin
Feb 21, 8:00AM Business Wire
Correction on $LGND , sorry... Japanese co holds the license on Bexarotene (Targretin) Eisai Co Ltd $4523.T
about 108 days ago by jvdg
$LGND Bexarotene approv. cancer drug is also treatment for Alzheimer, results now confirmed by university bio lab KU Leuven, gonna be huuuge
about 108 days ago by jvdg
$LGND is at $14.700 and is forming a base right now. When $LGND breaks above $15.910 on at least 174,027 share volume day,buy $LGND.
about 110 days ago by sundeeptrade
Pfizer Set To Seek Aprela Nod
Jan 30, 11:20PM The Wall Street Journal

Recent Quotes

Symbol Price Chg Chg % Market Cap
LGND 12.81 +0.15 +1.18% 249.15M
LGL 6.91 +0.05 +0.73% 17.83M
LGI 13.60 +0.10 +0.74%
LGF 12.75 -0.16 -1.24% 1.774B
LGCY 25.55 -0.53 -2.03% 1.250B
LG 38.29 +0.10 +0.26% 858.89M
LFUS 57.82 -0.95 -1.62% 1.270B
LFL 23.77 -0.54 -2.22% 8.273B
LFC 34.95 -1.19 -3.29% 17.93B
LF 10.37 -0.07 -0.67% 577.96M
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close